Skip to content
BG preceptorship

ESMO PRECEPTORSHIPS

State-of-the art educational courses delivered by ESMO faculty, offering an enriched and interactive learning experience

ABOUT ESMO PRECEPTORSHIPS

ESMO Preceptorships are in-person meetings combining plenary lectures and interactive case-based discussions led by a multidisciplinary faculty of 8-10 international experts. Each Preceptorship focuses on a specific malignancy or topic, giving oncologists a thorough understanding of disease management from diagnosis to treatment in line with current standards of care. 

ESMO Preceptorships cover a wide range of therapy areas

BREAST CANCER

GASTROINESTINAL CANCERS

GENITOURINARY CANCERS

GYNAECOLOGICAL CANCERS

THORACIC MALIGNANCIES

SUPPORTIVE CARE

2026 ESMO PRECEPTORSHIP CALENDAR

Breast cancer

ESMO Preceptorship on Breast Cancer 2026

 
16-18 JAN 2026 – MILAN, ITALY
GiuseppeCurigliano
Giuseppe Curigliano

Italy (Co-Chair)

BarbaraPistilli
Barbara Pistilli

France (Co-Chair)

Met Bladder & Kidney

ESMO Preceptorship on Metastatic Bladder & Kidney Cancer 2026

18-19 FEB 2026 – LUGANO, SWITZERLAND
RobertJones
Robert Jones

UK (Co-Chair)

CristinaSuarexRodriguez
Cristina Suarez Rodriguez

Spain (Co-Chair)

Christie Lung

ESMO - The Christie Preceptorship on Lung Cancer 2026

18-19 FEB 2026 – MANCHESTER, UK
FionaBlackhall
Fiona Blackhall

UK (Co-Chair)

RaffaeleCalifano
Raffaele Califano

UK (Co-Chair)

PilarGarridoLopez
Pilar Garrido Lopez

Spain (Co-Chair)

Head & Neck

ESMO Preceptorship on Head & Neck Cancer 2026

13-14 MAY 2026 – LUGANO, SWITZERLAND
SjoukjeOosting
Sjoukje Oosting

Netherlands (Co-Chair)

AmandaPsyrri
Amanda Psyrri

Greece (Co-Chair)

Colorectal Cancer

ESMO Preceptorship on Colorectal Cancer 2026

15-16 MAY 2026 – LUGANO, SWITZERLAND
AndresCervantes
Andrés Cervantes

Spain (Co-Chair)

ErikaMartinelli
Erika Martinelli

Italy (Co-Chair)

NSCLC

ESMO Preceptorship on Small Cell Lung Cancer 2026

24-25 JUN 2026 – LISBON, PORTUGAL
GiannisMountzios
Giannis Mountzios

Greece (Co-Chair)

KerstiOselin
Kersti Oselin

Estonia (Co-Chair)

Gastric Cancer

ESMO Preceptorship on Gastric Cancer 2026

26-27 JUN 2026 – LISBON, PORTUGAL
TaniaFleitas
Tania Fleitas

Spain (Co-Chair)

HannekevanLaarhoven
Hanneke van Laarhoven

Netherlands (Co-Chair)

Endometrial

ESMO Preceptorship on Endometrial Cancer 2026

1-2 JUL 2026 – LISBON, PORTUGAL
IlariaColombo
Ilaria Colombo

Switzerland (Co-Chair)

FabianTrillsch
Fabian Trillsch

Germany (Co-Chair)

Ovarian

ESMO Preceptorship on Ovarian Cancer 2026

8-9 JUL 2026 – MUNICH, GERMANY
SvenMaher
Sven Maher

Germany (Co-Chair)

AnaOaknin
Ana Oaknin

Spain (Co-Chair)

Breast cancer

ESMO Preceptorship on Breast Cancer 2026

10-11 JUL 2026 – MUNICH, GERMANY
NadiaHarbeck
Nadia Harbeck

Germany (Co-Chair)

PeterSchmid
Peter Schmid

UK (Co-Chair)

Tumour agnostic and cancer unknown primary

ESMO Preceptorship on Tumour Agnostic and Cancer of Unknown Primary 2026

18-19 SEP 2026 – ZURICH, SWITZERLAND
NatalieCook
Natalie Cook

UK (Co-Chair)

ChristophBenediktWestphalen
Christoph Benedikt Westphalen

Germany (Co-Chair)

Cachexia and Supportive

ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026

29-30 SEP – LUGANO, SWITZERLAND
KarinJordan
Karin Jordan

Germany (Co-Chair)

ChristinaRuhlmann
Christina Ruhlmann

Denmark (Co-Chair)

Colorectal Cancer

ESMO Preceptorship on Colorectal Cancer 2026

1-2 OCT 2026 – LUGANO, SWITZERLAND
DominikModest
Dominik Modest

Germany (Co-Chair)

JennySeligmann
Jenny Seligmann

UK (Co-Chair)

Prostate Cancer

ESMO Preceptorship on Prostate Cancer 2026

DATE TBC – COUNTRY TBC
3 Cristian Massacesi New York
Chair TBC

TBC (Co-Chair)

3 Cristian Massacesi New York
CHAIR TBC

TBC (Co-Chair)

NSCLC

ESMO Preceptorship on NSCLC 2026

JAN 2027 – HELSINKI, FINLAND
3 Cristian Massacesi New York
CHAIR TBC

TBC (Co-Chair)

3 Cristian Massacesi New York
Chair TBC

TBC (Co-Chair)

ESMO PRECEPTORSHIP METRICS 2025

PARTICIPANTS

594

Countries & Territories

57

Oncology Clinicians

58.7%

Abstracts presented

121

Programme Speakers

66

BENEFITS FOR OUR PARTNERS

EXTENSIVE COMPANY/LOGO RECOGNITION
3 OBSERVER SEATS PER COURSE
FULL OUTCOMES REPORT INCLUDING LIVE AND ON-DEMAND METRICS
2 YEAR WEBCAST PRESENCE ON ONCOLOGYPRO

FUNDING OPTIONS

Support type
Funding amount per sponsor (EUR)
100% funding (single sponsor) € 162,000
50% funding (2 sponsors) € 81,000
Support for ESMO-The Christie Preceptorship on Lung Cancer
Funding amount per sponsor (EUR)
25% funding (4 sponsors) € 75,000
Image 1
Image 2
Image3
Banner preceptorship

Download the prospectus to find out about sponsorship and funding opportunities

ESMO Preceptorships enquiry form

Please fill out this form to get in touch with us for questions related to ESMO Preceptorships